Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

ACC 2024 Congress

Catch up on all the top stories and latest evidence in cardiology research with our ACC 2024 Congress hub page.
ADVANCED SEARCH
Log in
Top
Clinical & Experimental Metastasis
Published in: Clinical & Experimental Metastasis 8/2003

01-12-2003

Rat colon carcinoma cells that survived systemic immune surveillance are less sensitive to NK-cell mediated apoptosis

Authors: Jurjen H.L. Velthuis, Miranda Stitzinger, Remco I.J.M. Aalbers, Hans J.G.M. de Bont, Gerard J. Mulder, Peter J.K. Kuppen, J. Fred Nagelkerke

Published in: Clinical & Experimental Metastasis | Issue 8/2003

Login to get access
Metadata
Title
Rat colon carcinoma cells that survived systemic immune surveillance are less sensitive to NK-cell mediated apoptosis
Authors
Jurjen H.L. Velthuis
Miranda Stitzinger
Remco I.J.M. Aalbers
Hans J.G.M. de Bont
Gerard J. Mulder
Peter J.K. Kuppen
J. Fred Nagelkerke
Publication date
01-12-2003
Publisher
Kluwer Academic Publishers
Published in
Clinical & Experimental Metastasis / Issue 8/2003
Print ISSN: 0262-0898
Electronic ISSN: 1573-7276
DOI
https://doi.org/10.1023/B:CLIN.0000006818.27267.03

Other articles of this Issue 8/2003

Clinical & Experimental Metastasis 8/2003 Go to the issue

OriginalPaper

Acknowledgements

OriginalPaper

S100A4 regulates membrane induced activation of matrix metalloproteinase-2 in osteosarcoma cells

OriginalPaper

Keyword Index to Volume 20

OriginalPaper

In vivo monitoring of tumor relapse and metastasis using bioluminescent PC-3M-luc-C6 cells in murine models of human prostate cancer

OriginalPaper

Melanoma invasion in reconstructed human skin is influenced by skin cells – investigation of the role of proteolytic enzymes

OriginalPaper

Comparative studies on the secretion and activation of MMPs in two reconstructed human skin models using HaCaT- and HaCaT-ras-transfected cell lines
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits